Gallic acid improves glucose tolerance and triglyceride concentration in diet-induced obesity mice

Eun Jung Bak, Jinmoon Kim, Sungil Jang, Gye Hyeong Woo, Ho Geun Yoon, Yun Jung Yoo, JeongHeon Cha

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Gallic acid, a phenolic phytochemical, has been shown to exert a variety of effects, including anti-oxidative, anti- carcinogenic, anti-allergic, and anti-inflammatory effects. In this study, we attempted to determine whether gallic acid affects metabolic syndrome such as obesity and diabetes. Diet-induced obesity mice were treated intraperitoneally once per day with gallic acid (10 mg/kg/day). After 2 weeks of treatment, the mice were sacrificed to collect the blood for metabolic parameter assessments, and the adipose tissues and liver to weigh and analyze. The triglyceride concentrations were significantly improved in the gallic acid group relative to those measured in the control group. And most importantly, the blood glucose concentrations in the gallic acid group were significantly improved. In the epididymal white adipose tissue of the gallic acid group, adipocyte size was reduced, PPARγ expression was induced, and the Akt signaling pathway was activated. Our results demonstrate that gallic acid improves glucose tolerance and lipid metabolism in the obesity mice, thereby showing evidence of anti-hyperglycemic activity. The findings of an upregulation of PPARγ expression and Akt activation also contribute to our current understanding of the mechanisms underlying the effects of gallic acid on glucose metabolism.

Original languageEnglish
Pages (from-to)607-614
Number of pages8
JournalScandinavian Journal of Clinical and Laboratory Investigation
Volume73
Issue number8
DOIs
Publication statusPublished - 2013 Dec 1

Fingerprint

Gallic Acid
Nutrition
Triglycerides
Obesity
Diet
Glucose
Peroxisome Proliferator-Activated Receptors
Tissue
Anti-Allergic Agents
White Adipose Tissue
Phytochemicals
Medical problems
Lipid Metabolism
Adipocytes
Metabolism
Liver
Blood Glucose
Adipose Tissue
Blood
Anti-Inflammatory Agents

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

Bak, Eun Jung ; Kim, Jinmoon ; Jang, Sungil ; Woo, Gye Hyeong ; Yoon, Ho Geun ; Yoo, Yun Jung ; Cha, JeongHeon. / Gallic acid improves glucose tolerance and triglyceride concentration in diet-induced obesity mice. In: Scandinavian Journal of Clinical and Laboratory Investigation. 2013 ; Vol. 73, No. 8. pp. 607-614.
@article{9ac1ddaecdbc49eb82d1aa490074ceba,
title = "Gallic acid improves glucose tolerance and triglyceride concentration in diet-induced obesity mice",
abstract = "Gallic acid, a phenolic phytochemical, has been shown to exert a variety of effects, including anti-oxidative, anti- carcinogenic, anti-allergic, and anti-inflammatory effects. In this study, we attempted to determine whether gallic acid affects metabolic syndrome such as obesity and diabetes. Diet-induced obesity mice were treated intraperitoneally once per day with gallic acid (10 mg/kg/day). After 2 weeks of treatment, the mice were sacrificed to collect the blood for metabolic parameter assessments, and the adipose tissues and liver to weigh and analyze. The triglyceride concentrations were significantly improved in the gallic acid group relative to those measured in the control group. And most importantly, the blood glucose concentrations in the gallic acid group were significantly improved. In the epididymal white adipose tissue of the gallic acid group, adipocyte size was reduced, PPARγ expression was induced, and the Akt signaling pathway was activated. Our results demonstrate that gallic acid improves glucose tolerance and lipid metabolism in the obesity mice, thereby showing evidence of anti-hyperglycemic activity. The findings of an upregulation of PPARγ expression and Akt activation also contribute to our current understanding of the mechanisms underlying the effects of gallic acid on glucose metabolism.",
author = "Bak, {Eun Jung} and Jinmoon Kim and Sungil Jang and Woo, {Gye Hyeong} and Yoon, {Ho Geun} and Yoo, {Yun Jung} and JeongHeon Cha",
year = "2013",
month = "12",
day = "1",
doi = "10.3109/00365513.2013.831470",
language = "English",
volume = "73",
pages = "607--614",
journal = "Scandinavian Journal of Clinical and Laboratory Investigation",
issn = "0036-5513",
publisher = "Informa Healthcare",
number = "8",

}

Gallic acid improves glucose tolerance and triglyceride concentration in diet-induced obesity mice. / Bak, Eun Jung; Kim, Jinmoon; Jang, Sungil; Woo, Gye Hyeong; Yoon, Ho Geun; Yoo, Yun Jung; Cha, JeongHeon.

In: Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 73, No. 8, 01.12.2013, p. 607-614.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Gallic acid improves glucose tolerance and triglyceride concentration in diet-induced obesity mice

AU - Bak, Eun Jung

AU - Kim, Jinmoon

AU - Jang, Sungil

AU - Woo, Gye Hyeong

AU - Yoon, Ho Geun

AU - Yoo, Yun Jung

AU - Cha, JeongHeon

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Gallic acid, a phenolic phytochemical, has been shown to exert a variety of effects, including anti-oxidative, anti- carcinogenic, anti-allergic, and anti-inflammatory effects. In this study, we attempted to determine whether gallic acid affects metabolic syndrome such as obesity and diabetes. Diet-induced obesity mice were treated intraperitoneally once per day with gallic acid (10 mg/kg/day). After 2 weeks of treatment, the mice were sacrificed to collect the blood for metabolic parameter assessments, and the adipose tissues and liver to weigh and analyze. The triglyceride concentrations were significantly improved in the gallic acid group relative to those measured in the control group. And most importantly, the blood glucose concentrations in the gallic acid group were significantly improved. In the epididymal white adipose tissue of the gallic acid group, adipocyte size was reduced, PPARγ expression was induced, and the Akt signaling pathway was activated. Our results demonstrate that gallic acid improves glucose tolerance and lipid metabolism in the obesity mice, thereby showing evidence of anti-hyperglycemic activity. The findings of an upregulation of PPARγ expression and Akt activation also contribute to our current understanding of the mechanisms underlying the effects of gallic acid on glucose metabolism.

AB - Gallic acid, a phenolic phytochemical, has been shown to exert a variety of effects, including anti-oxidative, anti- carcinogenic, anti-allergic, and anti-inflammatory effects. In this study, we attempted to determine whether gallic acid affects metabolic syndrome such as obesity and diabetes. Diet-induced obesity mice were treated intraperitoneally once per day with gallic acid (10 mg/kg/day). After 2 weeks of treatment, the mice were sacrificed to collect the blood for metabolic parameter assessments, and the adipose tissues and liver to weigh and analyze. The triglyceride concentrations were significantly improved in the gallic acid group relative to those measured in the control group. And most importantly, the blood glucose concentrations in the gallic acid group were significantly improved. In the epididymal white adipose tissue of the gallic acid group, adipocyte size was reduced, PPARγ expression was induced, and the Akt signaling pathway was activated. Our results demonstrate that gallic acid improves glucose tolerance and lipid metabolism in the obesity mice, thereby showing evidence of anti-hyperglycemic activity. The findings of an upregulation of PPARγ expression and Akt activation also contribute to our current understanding of the mechanisms underlying the effects of gallic acid on glucose metabolism.

UR - http://www.scopus.com/inward/record.url?scp=84887593467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887593467&partnerID=8YFLogxK

U2 - 10.3109/00365513.2013.831470

DO - 10.3109/00365513.2013.831470

M3 - Article

VL - 73

SP - 607

EP - 614

JO - Scandinavian Journal of Clinical and Laboratory Investigation

JF - Scandinavian Journal of Clinical and Laboratory Investigation

SN - 0036-5513

IS - 8

ER -